148 related articles for article (PubMed ID: 9378842)
1. Dependency of cortisol suppression on the administration time of inhaled corticosteroids.
Meibohm B; Hochhaus G; Rohatagi S; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
J Clin Pharmacol; 1997 Aug; 37(8):704-10. PubMed ID: 9378842
[TBL] [Abstract][Full Text] [Related]
2. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[TBL] [Abstract][Full Text] [Related]
3. An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy.
Krishnaswami S; Hochhaus G; Derendorf H
AAPS PharmSci; 2000; 2(3):E22. PubMed ID: 11741238
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952
[TBL] [Abstract][Full Text] [Related]
5. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
6. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults.
Brus R
Arch Intern Med; 1999 Sep; 159(16):1903-8. PubMed ID: 10493320
[TBL] [Abstract][Full Text] [Related]
7. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Nelson HS; Stricker W; Casale TB; Raff H; Fourré JA; Aron DC; Newman KB
J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety.
Derendorf H
Respir Med; 1997 Nov; 91 Suppl A():22-8. PubMed ID: 9474364
[TBL] [Abstract][Full Text] [Related]
10. Systemic effect comparisons of six inhaled corticosteroid preparations.
Martin RJ; Szefler SJ; Chinchilli VM; Kraft M; Dolovich M; Boushey HA; Cherniack RM; Craig TJ; Drazen JM; Fagan JK; Fahy JV; Fish JE; Ford JG; Israel E; Kunselman SJ; Lazarus SC; Lemanske RF; Peters SP; Sorkness CA
Am J Respir Crit Care Med; 2002 May; 165(10):1377-83. PubMed ID: 12016099
[TBL] [Abstract][Full Text] [Related]
11. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[TBL] [Abstract][Full Text] [Related]
12. Relative effects of exogenous inhaled corticosteroids on diurnal cortisol secretion.
Lipworth BJ
Arch Intern Med; 2000 Sep; 160(16):2549-50. PubMed ID: 10979076
[No Abstract] [Full Text] [Related]
13. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
[TBL] [Abstract][Full Text] [Related]
14. Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism.
Derendorf H; Hochhaus G; Krishnaswami S; Meibohm B; Möllmann H
Pharmazie; 2000 Mar; 55(3):223-7. PubMed ID: 10756545
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation.
Möllmann H; Derendorf H; Barth J; Meibohm B; Wagner M; Krieg M; Weisser H; Knöller J; Möllmann A; Hochhaus G
J Clin Pharmacol; 1997 Oct; 37(10):893-903. PubMed ID: 9505980
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
17. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
Wu K; Goyal N; Stark JG; Hochhaus G
J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
[TBL] [Abstract][Full Text] [Related]
19. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers.
Wilson AM; McFarlane LC; Lipworth BJ
J Clin Endocrinol Metab; 1998 Mar; 83(3):922-5. PubMed ID: 9506749
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
Volmer T; Kielhorn A; Weber HH; Wiessmann KJ
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
